Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
871
NCT01201837
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 31, 2011
Completion: Mar 31, 2013
NCT01412034
Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects
Start: Nov 30, 2011
Completion: Aug 31, 2014
NCT01515241
Exploratory Study of Plaque Regression
Start: Jan 31, 2012
Completion: May 31, 2012
NCT02484378
CER-001 Atherosclerosis Regression ACS Trial
Start: Aug 31, 2015
Completion: Dec 31, 2016
NCT02697136
CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases
Phase: Phase 3
Start: Dec 31, 2015
Completion: Dec 21, 2018